-
2
-
-
35348873634
-
Symptom burden among cancer survivors: Impact of age and comorbidity
-
Mao JJ, Armstrong K, Bowman MA, et al.: Symptom burden among cancer survivors: Impact of age and comorbidity. J Am Board Fam Med. 2007; 20(5): 434-443.
-
(2007)
J Am Board Fam Med
, vol.20
, Issue.5
, pp. 434-443
-
-
Mao, J.J.1
Armstrong, K.2
Bowman, M.A.3
-
3
-
-
33751022784
-
Multidisciplinary management of cancer pain: A longitudinal retrospective study on a cohort of end-stage cancer patients
-
Peng WL, Wu GJ, Sun WZ, et al.: Multidisciplinary management of cancer pain: A longitudinal retrospective study on a cohort of end-stage cancer patients. J Pain Symptom Manage. 2006; 32(5): 444-452.
-
(2006)
J Pain Symptom Manage
, vol.32
, Issue.5
, pp. 444-452
-
-
Peng, W.L.1
Wu, G.J.2
Sun, W.Z.3
-
4
-
-
34548405245
-
Prevalence of pain in patients with cancer: A systematic review of the past 40 years
-
DOI 10.1093/annonc/mdm056
-
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al.: Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol. 2007; 18(9): 1437-1449. (Pubitemid 47365475)
-
(2007)
Annals of Oncology
, vol.18
, Issue.9
, pp. 1437-1449
-
-
Van Den Beuken-van Everdingen, M.H.J.1
De Rijke, J.M.2
Kessels, A.G.3
Schouten, H.C.4
Van Kleef, M.5
Patijn, J.6
-
5
-
-
53949113349
-
Prevalence and treatment of cancer pain in Italian oncological wards centres: A cross-sectional survey
-
Mercadante S, Roila F, Berretto O, et al.: Prevalence and treatment of cancer pain in Italian oncological wards centres: A cross-sectional survey. Support Care Cancer. 2008; 16(11): 1203-1211.
-
(2008)
Support Care Cancer
, vol.16
, Issue.11
, pp. 1203-1211
-
-
Mercadante, S.1
Roila, F.2
Berretto, O.3
-
6
-
-
33845230217
-
An assessment of methods used to evaluate the adequacy of cancer pain management
-
Russell PB, Aveyard SC, Oxenham DR: An assessment of methods used to evaluate the adequacy of cancer pain management. J Pain Symptom Manage. 2006; 32(6): 581-588.
-
(2006)
J Pain Symptom Manage
, vol.32
, Issue.6
, pp. 581-588
-
-
Russell, P.B.1
Aveyard, S.C.2
Oxenham, D.R.3
-
7
-
-
14844331712
-
Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome
-
Macdonald L, Bruce J, Scott NW, et al.: Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer. 2005; 92(2): 225-230.
-
(2005)
Br J Cancer
, vol.92
, Issue.2
, pp. 225-230
-
-
Macdonald, L.1
Bruce, J.2
Scott, N.W.3
-
8
-
-
18844378628
-
Palliative care needs of cancer patients in U.S. nursing homes
-
Johnson VM, Teno JM, Bourbonniere M, et al.: Palliative care needs of cancer patients in U.S. nursing homes. J Palliat Med. 2005; 8(2): 273-279.
-
(2005)
J Palliat Med
, vol.8
, Issue.2
, pp. 273-279
-
-
Johnson, V.M.1
Teno, J.M.2
Bourbonniere, M.3
-
9
-
-
33845863702
-
Pain management in the last six months of life among women who died of ovarian cancer
-
Rolnick SJ, Jackson J, Nelson WW, et al.: Pain management in the last six months of life among women who died of ovarian cancer. J Pain Symptom Manage. 2007; 33(1): 24-31.
-
(2007)
J Pain Symptom Manage
, vol.33
, Issue.1
, pp. 24-31
-
-
Rolnick, S.J.1
Jackson, J.2
Nelson, W.W.3
-
10
-
-
56749182291
-
Prevalence of undertreatment in cancer pain. A review of published literature
-
Deandrea S, Montanari M, Moja L, et al.: Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008; 19(12): 1985-1991.
-
(2008)
Ann Oncol
, vol.19
, Issue.12
, pp. 1985-1991
-
-
Deandrea, S.1
Montanari, M.2
Moja, L.3
-
12
-
-
0003527864
-
-
World Health Organization: Geneva, Switzerland: WHO Office of Publication
-
World Health Organization: Cancer Pain Relief. Geneva, Switzerland: WHO Office of Publication, 1996.
-
(1996)
Cancer Pain Relief
-
-
-
13
-
-
0028848482
-
Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study
-
Zech DF, Grond S, Lynch J, et al.: Validation of World Health Organization Guidelines for cancer pain relief: A 10-year prospective study. Pain. 1995; 63(1): 65-76.
-
(1995)
Pain
, vol.63
, Issue.1
, pp. 65-76
-
-
Zech, D.F.1
Grond, S.2
Lynch, J.3
-
15
-
-
0029146394
-
Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration
-
Cherny NJ, Chang V, Frager G, et al.: Opioid pharmacotherapy in the management of cancer pain: A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer. 1995; 76(7): 1283-1293.
-
(1995)
Cancer
, vol.76
, Issue.7
, pp. 1283-1293
-
-
Cherny, N.J.1
Chang, V.2
Frager, G.3
-
16
-
-
31044445939
-
No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients
-
DOI 10.1007/s00520-005-0843-2
-
Riley J, Ross JR, Rutter D, et al.: No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer. 2006; 14(1): 56-64. (Pubitemid 43119598)
-
(2006)
Supportive Care in Cancer
, vol.14
, Issue.1
, pp. 56-64
-
-
Riley, J.1
Ross, J.R.2
Rutter, D.3
Wells, A.U.4
Goller, K.5
Du Bois, R.6
Welsh, K.7
-
17
-
-
69849084738
-
Opioid switching and rotation in primary care: Implementation and clinical utility
-
Slatkin NE: Opioid switching and rotation in primary care: Implementation and clinical utility. Curr Med Res Opin. 2009; 25(9): 2133-2150.
-
(2009)
Curr Med Res Opin
, vol.25
, Issue.9
, pp. 2133-2150
-
-
Slatkin, N.E.1
-
18
-
-
0035059131
-
Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR)
-
Coluzzi PH, Schwartzberg L, Conroy JD, et al.: Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001; 91(1-2): 123-130.
-
(2001)
Pain
, vol.91
, Issue.1-2
, pp. 123-130
-
-
Coluzzi, P.H.1
Schwartzberg, L.2
Conroy, J.D.3
-
19
-
-
0017580705
-
Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer
-
Beaver WT, Wallenstein SL, Houde RW, et al.: Comparisons of the analgesic effects of oral and intramuscular oxymorphone and of intramuscular oxymorphone and morphine in patients with cancer. J Clin Pharmacol. 1977; 17(4): 186-198.
-
(1977)
J Clin Pharmacol
, vol.17
, Issue.4
, pp. 186-198
-
-
Beaver, W.T.1
Wallenstein, S.L.2
Houde, R.W.3
-
20
-
-
0035866624
-
Investigation of the selectivity of oxymorphone- And naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: Exploring the "address" recognition locus
-
Metzger TG, Paterlini MG, Ferguson DM, et al.: Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: Exploring the "address" recognition locus. J Med Chem. 2001; 44(6): 857-862.
-
(2001)
J Med Chem
, vol.44
, Issue.6
, pp. 857-862
-
-
Metzger, T.G.1
Paterlini, M.G.2
Ferguson, D.M.3
-
21
-
-
1842480273
-
Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: Results of a randomized crossover study
-
Adams MP, Ahdieh H: Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: Results of a randomized crossover study. Pharmacotherapy. 2004; 24(4): 468-476.
-
(2004)
Pharmacotherapy
, vol.24
, Issue.4
, pp. 468-476
-
-
Adams, M.P.1
Ahdieh, H.2
-
22
-
-
33846635073
-
Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study
-
Hale ME, Ahdieh H, Ma T, et al.: Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: A 12-week, randomized, double-blind, placebo-controlled study. J Pain. 2007; 8(2): 175-184.
-
(2007)
J Pain
, vol.8
, Issue.2
, pp. 175-184
-
-
Hale, M.E.1
Ahdieh, H.2
Ma, T.3
-
23
-
-
33846671273
-
A 12-week randomized placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain
-
Katz N, Rauck R, Ahdieh H, et al.: A 12-week randomized placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin. 2007; 23(1): 117-128.
-
(2007)
Curr Med Res Opin
, vol.23
, Issue.1
, pp. 117-128
-
-
Katz, N.1
Rauck, R.2
Ahdieh, H.3
-
24
-
-
17144390270
-
Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: A one-year study
-
McIlwain H, Ahdieh H: Safety, tolerability, and effectiveness of oxymorphone extended release for moderate to severe osteoarthritis pain: A one-year study. Am J Ther. 2005; 12(2): 106-112.
-
(2005)
Am J Ther
, vol.12
, Issue.2
, pp. 106-112
-
-
McIlwain, H.1
Ahdieh, H.2
-
25
-
-
3042595723
-
Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: A randomized controlled study
-
Gabrail NY, Dvergsten C, Ahdieh H: Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: A randomized controlled study. Curr Med Res Opin. 2004; 20(6): 911-918.
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.6
, pp. 911-918
-
-
Gabrail, N.Y.1
Dvergsten, C.2
Ahdieh, H.3
-
26
-
-
13244272132
-
Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: A pilot study
-
Sloan P, Slatkin N, Ahdieh H: Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: A pilot study. Support Care Cancer. 2005; 13(1): 57-65.
-
(2005)
Support Care Cancer
, vol.13
, Issue.1
, pp. 57-65
-
-
Sloan, P.1
Slatkin, N.2
Ahdieh, H.3
-
27
-
-
20644431597
-
Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials
-
Eisenberg E, McNicol ED, Carr DB: Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: Systematic review and meta-analysis of randomized controlled trials. JAMA. 2005; 293(24): 3043-3052.
-
(2005)
JAMA
, vol.293
, Issue.24
, pp. 3043-3052
-
-
Eisenberg, E.1
McNicol, E.D.2
Carr, D.B.3
-
28
-
-
52949098347
-
Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain
-
Rauck R, Ma T, Kerwin R, et al.: Titration with oxymorphone extended release to achieve effective long-term pain relief and improve tolerability in opioid-naive patients with moderate to severe pain. Pain Med. 2008; 9(7): 777-785.
-
(2008)
Pain Med
, vol.9
, Issue.7
, pp. 777-785
-
-
Rauck, R.1
Ma, T.2
Kerwin, R.3
-
29
-
-
0031740844
-
Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain
-
Citron ML, Kaplan R, Parris WC, et al.: Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain. Cancer Invest. 1998; 16(8): 562-571. (Pubitemid 28541776)
-
(1998)
Cancer Investigation
, vol.16
, Issue.8
, pp. 562-571
-
-
Citron, M.L.1
Kaplan, R.2
Parris, W.C.-V.3
Croghan, M.K.4
Herbst, L.H.5
Rosenbluth, R.J.6
Reder, R.F.7
Slagle, N.S.8
Buckley, B.J.9
Kaiko, R.F.10
-
30
-
-
33745960058
-
Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials
-
Likar R, Kayser H, Sittl R: Long-term management of chronic pain with transdermal buprenorphine: A multicenter, open-label, follow-up study in patients from three short-term clinical trials. Clin Ther. 2006; 28(6): 943-952.
-
(2006)
Clin Ther
, vol.28
, Issue.6
, pp. 943-952
-
-
Likar, R.1
Kayser, H.2
Sittl, R.3
-
31
-
-
65749098996
-
Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain
-
Wallace M, Moulin DE, Rauck RL, et al.: Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain. J Opioid Manag. 2009; 5(2): 97-105.
-
(2009)
J Opioid Manag
, vol.5
, Issue.2
, pp. 97-105
-
-
Wallace, M.1
Moulin, D.E.2
Rauck, R.L.3
-
32
-
-
70349832927
-
An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain
-
Hanna M, Tuca A, Thipphawong J: An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS(R) hydromorphone in patients with chronic cancer pain. BMC Palliat Care. 2009; 8: 14.
-
(2009)
BMC Palliat Care
, vol.8
, pp. 14
-
-
Hanna, M.1
Tuca, A.2
Thipphawong, J.3
-
33
-
-
19544371019
-
Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: A multicenter, open-label, uncontrolled, prospective, observational clinical study
-
Muriel C, Failde I, Mico JA, et al.: Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: A multicenter, open-label, uncontrolled, prospective, observational clinical study. Clin Ther. 2005; 27(4): 451-462.
-
(2005)
Clin Ther
, vol.27
, Issue.4
, pp. 451-462
-
-
Muriel, C.1
Failde, I.2
Mico, J.A.3
|